Learnings from the First R-Based Submission to FDA by Novo Nordisk
Explore Novo Nordisk's pioneering R-based submission to the FDA, highlighting strategies and key insights in pharmaceutical compliance.
Join the Shiny Community every month at Shiny Gatherings
Explore Novo Nordisk's pioneering R-based submission to the FDA, highlighting strategies and key insights in pharmaceutical compliance.